Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration

• Status: Recruiting
• Trial end date: 2025-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of Usual versus Reduced Lipid Intake on Unbound Bilirubin Levels, Brainstem Auditory Evoked Potentials, and neurodevelopmental Outcome at 2 Years in Extremely Preterm Infants

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Treatments: Soybean oil, phospholipid emulsion

Criteria

Inclusion Criteria:

• no major congenital anomaly or overt nonbacterial infection

• mother has consented to inclusion of the infant for the Neonatal Research Network (NRN) Cycled Phototherapy Trial

Exclusion Criteria:

• has received Intralipid